Current discharge management of acute coronary syndromes: Baseline results from a national quality improvement initiative

Internal Medicine Journal

Volumn 42, Issue 5, 2012, Pages

  Wai, A ^a   Pulver, L K ^c   Oliver, K ^b   Thompson, A ^d  

^a National Prescribing Service Ltd   (Australia)

^b New South Wales Therapeutic Advisory Group   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Acute coronary syndromes; Drug utilisation review; Evidence based medicine; Patient discharge

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DRUG USE; DYSLIPIDEMIA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEART REHABILITATION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PATIENT COUNSELING; PATIENT REFERRAL; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TOTAL QUALITY MANAGEMENT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AUSTRALIA; DISEASE MANAGEMENT; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES;

EID: 84861445077     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02308.x     Document Type: Article

References (19)

1. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases, Australian facts 2004. Cardiovascular disease series No22. Vol. AIHW catalogue No. CVD 27. Canberra: AIHW 2004.
2. Aroney CN, Aylward P, Kelly AM, Chew DPB, Cline E, on behalf of the Acute Coronary Syndromes Guidelines Working Group. National Heart Foundation of Australia Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes. Med J Aust 2006; 184 (suppl): s1-s30.
3. Hickey AC, Scott IA, Denaro CP, Stewart N, Bennet CJ, Theile T. Using clinical indicators in a quality improvement programme targeting cardiac care. Int J Qual Health Care 2004; 16: i11-i25.
4. Scott IA, Denaro CP, Bennett CJ, Hickey AC, Mudge AM, Flores JL etal. Achieving better in-hospital and after-hospital care of patients with acute cardiac disease. Med J Aust 2004; 180: s83-s88.
5. Chew DP, Amerena J, Brieger D. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J 2007; 37: 741-8.
6. Scott IA, Derrhy PH, O'Kane D, Lindsay KA, Atherton JJ, Jones MA etal. Discordance between level of risk and intensity of evidence based treatment in patients with acute coronary syndromes. Med J Aust 2007; 187: 153-9.
7. Higgins RO, Murphy BM, Goble AJ, Le Grande MR, Elliott PC, Worcester MUC. Cardiac rehabilitation program attendance after coronary artery bypass surgery: overcoming the barriers. Med J Aust 2008; 188: 712-14.
8. Bunker S, McBurney H, Cox H, Jelinek M. Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia. J Cardiopulm Rehabil 1999; 19: 334-8.
9. Scott IA, Lindsay KA, Harden HE. Utilisation of outpatient cardiac rehabilitation in Queensland. Med J Aust 2003; 179: 341-5.
10. Dartnell JGA. Understanding, Influencing and Evaluating Drug Use. Melbourne: Therapeutic Guidelines Limited; 2001.
11. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Drug Usage Evaluation. Australian Drug Usage Evaluation (DUE) Starter Kit: the Society of Hospital Pharmacists of Australia. 2004.
12. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Drug Use Evaluation. The Society of Hospital Pharmacists of Australia Standards of practice for drug use evaluation in Australian hospitals. J Pharm Pract Res 2004; 34: 220-23.
13. Cooper A, Skinner J, Nherera L, Feder G, Ritchie G, Kathoria M etal. Clinical Guidelines and Evidence Review for Post Myocardial Infarction: Secondary Prevention in Primary and Secondary Care for Patients Following A Myocardial Infarction. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2007.
14. Chew DP, Amerena JV, Coverdale SG, Rankin JM, Astley CM, Soman A etal. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust 2008; 188: 691-7.
15. Mukherjee D, Fang J, Kline-Rogers E, Otten R, Eagle KA. Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups. Heart 2005; 91: 381-2.
16. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ etal. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-7.
17. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: National Heart Foundation of Australia. 2007 (updated 2008).
18. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K etal. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116: 682-92.
19. Brown TM, Hernandez AF, Bittner V, Cannon CP, Ellrodt G, Liang L etal. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get with the Guidelines Program. J Am Coll Cardiol 2009; 54: 515-21.